US FDA approves Viltepso injection for treatment of Duchenne muscular dystrophy mutation
The approval was granted to NS Pharma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
dystrophin gene mutation
FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy…
It is estimated that about 8 percent of patients with DMD have mutation of the dystrophin gene that is amenable to exon 53…